IRIS
CUTOLO, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 58.961
Totale 58.961
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 58.961
Totale 58.961
Salva come PNG Salva come JPEG
Città #
Genova 49.232
Rapallo 5.497
Genoa 4.075
Bordighera 157
Totale 58.961
Salva come PNG Salva come JPEG
Nome #
Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. 509
1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. 180
The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases 155
Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments. 149
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 149
Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal 148
Androgens in rheumatoid arthritis: when are they effectors? 145
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 142
Steroids and Autoimmunity 140
Zinc concentrations in rheumatoid and psoriatic arthritis. Are they relevant to the inflammatory process? 137
Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms. 136
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 136
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 136
Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. 135
Functional study of glenohumeral ligaments. 135
Evolutionary medicine and bone loss in chronic inflammatory diseases-A theory of inflammation-related osteopenia 134
Rheumatoid arthritis: circadian and circannual rhythms in RA. 132
Special issue on glucocorticoid therapy in rheumatic diseases: introduction 132
The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. 130
The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis. 128
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. 128
Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines 128
European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO). 127
Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice 126
Clinical trials documenting the efficacy of low-dose glucocorticoids in rheumatoid arthritis 126
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 125
CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production. 124
Timing of transition between capillaroscopic patterns in systemic sclerosis. 124
Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. 123
Pregnancy, cytokines and disease activity in systemic lupus erythematosus 123
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. 123
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. 122
Modulation of cell growth and apoptosis by sex hormones in cultured monocytic THP-1 cells. 122
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 121
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 121
Lack of sialic acid in synovial fluid fibronectin. 120
Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis 120
Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients 120
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. 119
Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. 119
Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study 119
Therapy. Optimized treatment algorithms for digital vasculopathy in SSc. 119
Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. 119
Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. 118
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. 118
Cross-cultural adaptation and validity of the Italian version of the Central Sensitization Inventory 118
Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. 118
Nocturnal hormones and clinical rhythms in rheumatoid arthritis. 117
Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern 117
[CTLA4-Ig interferes and downregulates the proinflammatory activities of rheumatoid synovial macrophages in monoculture] 116
Acral localized acquired cutis laxa associated with rheumatoid arthritis. 116
Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis. 116
Estrogen's effects in chronic autoimmune/inflammatory diseases and progression to cancer 115
Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study. 115
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 115
Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). 115
Systemic sclerosis: state of the art on clinical practice guidelines 115
Vitamin D endocrine system and the immune response in rheumatic diseases. 114
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis 114
Immunomodulatory mechanisms mediated by sex hormones in rheumatoid arthritis. 113
Oral low-dose glucocorticoids should be included in any recommendation for the use of non-biologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis 113
Air Travel, Circadian Rhythms/Hormones, and Autoimmunity. 113
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 113
Vitamin D endocrine system involvement in autoimmune rheumatic diseases 113
The controversy over zinc sulphate efficacy in rheumatoid and psoriatic arthritis. 112
Rapid interaction between CTLA4-Ig (abatacept) and synovial macrophages from patients with rheumatoid arthritis. 112
Nail involvement in osteoarthritis. 112
Androgen replacement therapy in male patients with rheumatoid arthritis. 111
Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis. 111
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 111
Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis 111
Evidence for increase in finger blood flow, evaluated by laser Doppler flowmetry, following iloprost infusion in patients with systemic sclerosis: a week-long observational longitudinal study 111
Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients 111
2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis 111
Stress as a risk factor in the pathogenesis of rheumatoid arthritis. 110
Phorbol diester 12-O-tetradecanoylphorbol 13-acetate (TPA) up-regulates the expression of estrogen receptors in human THP-1 leukemia cells. 110
Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional? 110
Review: vitamin D, immunity and lupus. 109
Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus. 109
Interspinous bursitis is common in polymyalgia rheumatica, but is not associated with spinal pain 109
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 109
Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA to measure peripheral blood perfusion in scleroderma patients. 109
Introduction: new trends in pregnancy and rheumatic diseases. 109
Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside. 109
EULAR evidence based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. 109
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force 109
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey). 109
Estrogens in pregnancy and systemic lupus erythematosus. 108
Adult-onset Still's disease associated to toxoplasma gondii infection. 108
Atlas of Capillaroscopy in Rheumatic Diseases 108
Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis 108
Hypocupremia-related hypochromic anemia during D-penicillamine treatment. 108
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients 108
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3. 108
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. 108
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. 108
Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. 108
Sjögren's syndrome: state of the art on clinical practice guidelines 108
Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of antiinflammatory action. 107
Evidence for soluble and nuclear site I binding of estrogens in human aorta. 107
Totale 12.363
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.747
article - articoli 146.310
book - libri 0
conference - conferenze 5.497
curatela - curatele 182
other - altro 55
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.703
Totale 307.494
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.734 0 0 0 0 0 0 0 0 0 0 1.460 1.274
2019/202018.999 805 555 737 1.119 1.681 1.921 2.959 1.399 1.743 3.269 2.071 740
2020/20215.401 313 396 872 368 378 467 276 416 567 552 387 409
2021/20228.378 239 593 656 959 201 481 581 2.043 473 795 323 1.034
2022/20236.782 806 249 50 569 1.237 1.159 47 662 1.194 61 660 88
2023/20243.133 187 657 83 378 299 647 258 343 192 80 9 0
Totale 60.686